A narrative review of radiomics and deep learning advances in neuroblastoma: updates and challenges
- 10 November 2023
- journal article
- review article
- Published by Springer Nature in Pediatric Radiology
- Vol. 53 (13) , 2742-2755
Abstract
Neuroblastoma is an extremely heterogeneous tumor that commonly occurs in children. The diagnosis and treatment of this tumor pose considerable challenges due to its varied clinical presentations and intricate genetic aberrations. Presently, various imaging modalities, including computed tomography, magnetic resonance imaging, and positron emission tomography, are utilized to assess neuroblastoma. Nevertheless, these conventional imaging modalities have limitations in providing quantitative information for accurate diagnosis and prognosis. Radiomics, an emerging technique, can extract intricate medical imaging information that is imperceptible to the human eye and transform it into quantitative data. In conjunction with deep learning algorithms, radiomics holds great promise in complementing existing imaging modalities. The aim of this review is to showcase the potential of radiomics and deep learning advancements to enhance the diagnostic capabilities of current imaging modalities for neuroblastoma. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of Chongqing ((CSTB)2023NSCQ-BHX0127)
This publication has 63 references indexed in Scilit:
- Research progress of neuroblastoma related gene variationsOncotarget, 2016
- NeuroblastomaNature Reviews Disease Primers, 2016
- The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high‐risk neuroblastomaCancer, 2012
- Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithmBritish Journal of Radiology, 2011
- The Connections Between Neural Crest Development and Neuroblastoma2011
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeBritish Journal of Cancer, 2009
- Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signatureOncogene, 2007
- The International Neuroblastoma Pathology Classification (the Shimada system)Cancer, 1999
- Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.1999
- The International Neuroblastoma Pathology Classification (the Shimada system).1999